Speech-Language Pathologists in Sheridan, MT Accepting Medicare
2 Speech-Language Pathologists found. Showing 1 - 2
 Tanya Rose Curtis, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 203 S Main, Sheridan, MT 59749 Phone: 877-801-0024 Fax: 877-801-0024 |
 Augcom Solutions, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 203 S Main, Sheridan, MT 59749 Phone: 877-801-0024 Fax: 877-801-0024 |
News Archive
Ivy Center opens new clinical trial to evaluate experimental drug cocktail for glioblastoma
The Ivy Brain Tumor Center at Barrow Neurological Institute announced that patient recruitment has opened for a new Phase 0 clinical trial to evaluate two targeted therapy drugs, abemaciclib and LY3214996.
G20 agriculture ministers should focus on small farmers to address food price volatility
"When the G20 Ministers of Agriculture develop an action plan to address food price volatility and its impact on the poor, they should focus on both urgent actions and the vital role of smallholder farmers," Shenggen Fan, director-general of the International Food Policy Research Institute, writes in an Inter Press Service opinion piece.
Children born preterm remain at high risk of developmental difficulties, finds study
Children born preterm (before 37 weeks of pregnancy) remain at high risk of developmental difficulties that can affect their behaviour and ability to learn, finds a study published by The BMJ today.
Induced pluripotent cells may make embryonic stem cells unnecessary
For nearly two decades, the medical world and the American public have grappled with the lightning-rod topic of stem cells, in particular the controversy surrounding cells from human embryos. But when researchers four years ago successfully "reprogrammed" adult body cells to become stem cells, some thought the ethical debate was nearly over. Those redirected cells, known as induced pluripotent cells, or iPS cells, show potential as therapy.
Broad Institute, UC Berkeley and UCSC receive NCI Cancer Genomics Cloud Pilot contract
A team from the Broad Institute, the University of California, Berkeley, and the University of California, Santa Cruz, was awarded one of three National Cancer Institute Cancer Genomics Cloud Pilot contracts with the goal of building a system that will enable large-scale analysis of The Cancer Genome Atlas and other datasets by co-locating the data and the required computing resources in one cloud environment.
› Verified 7 days ago